Skip to main content
SpringerLink
Log in

Borderline Tumor (Serous/Mucinous/Endometrioid) (Clinical Setting and US)

  • Chapter
  • First Online:
Ovarian Neoplasm Imaging

  • 1874 Accesses

Abstract

Borderline ovarian tumors are epithelial tumors with a low growth rate and a low potential to invade or metastasize. These tumors have been studied with increased interest over the past decade. A pathologic definition was accepted by the International Federation of Gynecology and Obstetrics. They differ from malignant tumors because of the absence of stromal invasion in the former tumors, without regard to the features of any coexisting extraovarian disease.

Transvaginal sonography is the primary screening imaging technique in patients with ovarian masses. Borderline ovarian tumors are more difficult to diagnose correctly than benign and invasive malignant ovarian tumors.

Though various studies have described the morphological characteristics of borderline tumors, actually no ultrasound rule has up to now demonstrated the ability to discriminate, with high accuracy, a borderline tumor from a benign tumor or from an invasive tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ahmed ASM, Lawton FG. Borderline ovarian tumours: current concepts and management. Rev Gynaecol Pract. 2005;5:139–51.

    Article  Google Scholar 

  2. Andersen ES, Knudsen A, Rix P, et al. Risk of malignancy index in the preoperative evaluation of patients with adnexal masses. Gynecol Oncol. 2003;90:109–12.

    Article  PubMed  Google Scholar 

  3. Bazot M, Darai E, Nassar-Slaba J, et al. Value of magnetic resonance imaging for the diagnosis of ovarian tumors: a review. J Comput Assist Tomogr. 2008;32:712–23.

    Article  PubMed  Google Scholar 

  4. Bazot M, Nassar-Slaba J, Thomassin-Naggara I, et al. MR imaging compared with intraoperative frozen-section examination for the diagnosis of adnexal tumors; correlation with final histology. Eur Radiol. 2006;16:2687–99.

    Article  PubMed  Google Scholar 

  5. Boran N, Cil AP, Tulunay G, et al. Fertility and recurrence results of conservative surgery for borderline ovarian tumors. Gynecol Oncol. 2005;97:845–51.

    Article  PubMed  Google Scholar 

  6. Borgfeldt C, Iosif C, Masback A. Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer. Eur J Obstet Gynecol Reprod Biol. 2007;134:110–4.

    Article  PubMed  Google Scholar 

  7. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol. 1996;20:1319–30.

    Article  CAS  PubMed  Google Scholar 

  8. Cadron I, Amant F, Van Grop T, et al. The management of borderline tumours of the ovary. Curr Opin Oncol. 2006;18:488–93.

    Article  PubMed  Google Scholar 

  9. Cadron I, Leunen K, Van Gorp T, et al. Management of borderline ovarian neoplasms. J Clin Oncol. 2007;25:2928–37.

    Article  PubMed  Google Scholar 

  10. Castellucci P, Perrone AM, Picchio M, et al. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology. Nucl Med Commun. 2007;28:589–95.

    Article  CAS  PubMed  Google Scholar 

  11. Crispens MA, Bodurka D, Deavers M, et al. Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential. ACOG. 2002;99:3–10.

    Google Scholar 

  12. Darai E, Teboul J, Walker F, et al. Epithelial ovarian carcinoma of low malignant potential. Eur J Obstet Gynecol Reprod Biol. 1996;66:141–5.

    Article  CAS  PubMed  Google Scholar 

  13. Deavers MT, Gershenson DM, Tortolero-Luna G, et al. Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases. Am J Surg Pathol. 2002;26:1129–41.

    Article  PubMed  Google Scholar 

  14. Dehari R, Robert J, Kurman RJ, et al. The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma a morphologic and molecular genetic analysis. Am J Surg Pathol. 2007;31:1007–12.

    Article  PubMed  Google Scholar 

  15. Desfeux P, Bats AS, Bensaid C, et al. Impact of the surgical route on staging and outcome of early borderline ovarian tumors. Gynecol Obstet Fertil. 2007;35:193–8.

    Article  CAS  PubMed  Google Scholar 

  16. Donnez J, Munschke A, Berliere M, et al. Safety of conservative management and fertility outcome in women with borderline tumors of the ovary. Fertil Steril. 2003;79:1216–21.

    Article  PubMed  Google Scholar 

  17. Eichhorn JH, Bell DA, Young RH, et al. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol. 1999;23:397–409.

    Article  CAS  PubMed  Google Scholar 

  18. Emoto M, Udo T, Obama H, et al. The blood flow characteristics in borderline ovarian tumors based on both color Doppler ultrasound and histopathologic analyses. Gynecol Oncol. 1998;70:351–7.

    Article  CAS  PubMed  Google Scholar 

  19. Engelen MJ, de Bruijn HW, Hollema H, et al. Serum CA 125, carcinoembryonic antigen, and CA 19–9 as tumor markers in borderline ovarian tumors. Gynecol Oncol. 2000;78:16–20.

    Article  CAS  PubMed  Google Scholar 

  20. Eskander RN, Randall LM, Berman ML, et al. Fertility preserving options in patients with gynecologic malignancies. Am J Obstet Gynecol. 2011;205:103–10.

    Article  PubMed  Google Scholar 

  21. Exacoustos C, Romanini ME, Rinaldo D, et al. Preoperative sonographic features of borderline ovarian tumors. Ultrasound Obstet Gynecol. 2005;25:50–9.

    Article  CAS  PubMed  Google Scholar 

  22. Fagotti A, Ludovisi M, De Blasis I, et al. The sonographic prediction of invasive carcinoma in unilocular-solid ovarian cysts in premenopausal patients: a pilot study. Hum Reprod. 2012;27:2676–83.

    Article  CAS  PubMed  Google Scholar 

  23. Fauvet R, Poncelet C, Boccara J, et al. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study. Fertil Steril. 2005;83:284–90.

    Article  PubMed  Google Scholar 

  24. Ferreira CR, Carvalho JP, Soares FA, et al. Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors. Int J Gynecol Cancer. 2008;18:59–65.

    Article  CAS  PubMed  Google Scholar 

  25. Fruscella E, Testa AC, Ferrandina G, et al. Ultrasound features of different histopathologic subtypes of borderline ovarian tumors. Ultrasound Obstet Gynecol. 2005;26:644–50.

    Article  CAS  PubMed  Google Scholar 

  26. Gershenson DM. Clinical management potential tumors of low malignancy. Best Pract Res Clin Obstet Gynaecol. 2002;16:513–27.

    Article  PubMed  Google Scholar 

  27. Gilks CB, Alkushi A, Yue JJ, et al. Advanced-stage serous borderline tumors of the ovary: a clinicopathologic study of 49 cases. Int J Gynecol Pathol. 2003;22:29–36.

    Article  PubMed  Google Scholar 

  28. Gotlieb WH, Flikker S, Davidson B, et al. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome. Cancer. 1998;82:141–6.

    Article  CAS  PubMed  Google Scholar 

  29. Gotlieb WH, Soriano D, Achiron R, et al. CA 125 measurement and ultrasonography in borderline tumors of the ovary. Am J Obstet Gynecol. 2000;183:541–6.

    Article  CAS  PubMed  Google Scholar 

  30. Ha JE, Jueng IC, Lee YS, et al. Clinical analysis of borderline ovarian tumors. Eur J Gynaecol Oncol. 2011;22:69–72.

    Google Scholar 

  31. Hassen K, Ghossain MA, Rousset P, Sciot C, et al. Characterization of papillary projections in benign versus borderline and malignant ovarian masses on conventional and color Doppler ultrasound. AJR Am J Roentgenol. 2011;196:1444–9.

    Article  PubMed  Google Scholar 

  32. Hata K, Hata T, Manabe A, et al. Ovarian tumors of low malignant potential: transvaginal Doppler ultrasound features. Gynecol Oncol. 1992;45:259–64.

    Article  CAS  PubMed  Google Scholar 

  33. Hillaby K, Aslam N, Salim R, et al. The value of detection of normal ovarian tissue (the ‘ovarian crescent sign’) in the differential diagnosis of adnexal masses. Ultrasound Obstet Gynecol. 2004;23:63–7.

    Article  CAS  PubMed  Google Scholar 

  34. Houck K, Nikrui N, Duska L, et al. Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis. Obstet Gynecol. 2000;95(6):839–43.

    Article  CAS  PubMed  Google Scholar 

  35. Hricak H, Chen M, Coakley FV, et al. Complex adnexal masses: detection and characterization with MR imaging – multivariate analysis. Radiology. 2000;214:39–46.

    Article  CAS  PubMed  Google Scholar 

  36. International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumors in the female pelvis. Acta Obstet Gynecol Scand. 1971;50:1–7.

    Google Scholar 

  37. Jokubkiene L, Sladkevicius P, Valentin L. Does three-dimensional power Doppler ultrasound help in discrimination between benign and malignant ovarian masses? Ultrasound Obstet Gynecol. 2007;29:215–25.

    Article  CAS  PubMed  Google Scholar 

  38. Jones MB. Borderline ovarian tumors: current concepts for prognostic factors and clinical management. Clin Obstet Gynecol. 2006;49:517–25.

    Article  PubMed  Google Scholar 

  39. Jung DC, Choi HJ, Ju W, et al. Discordant MRI/FDG-PET imaging for the diagnosis of borderline ovarian tumors. Int J Gynecol Cancer. 2008;18:637–41.

    Article  CAS  PubMed  Google Scholar 

  40. Kayikcioglu F, Pata O, Cengiz S, et al. Accuracy of frozen section diagnosis in borderline ovarian malignancy. Gynecol Obstet Invest. 2000;49:187–9.

    Article  CAS  PubMed  Google Scholar 

  41. Kennedy AW, Hart WR. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors): a long term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma. Cancer. 1996;78:278–86.

    Article  CAS  PubMed  Google Scholar 

  42. Kikkawa F, Nawa A, Kajiyama H, et al. Clinical characteristics and prognosis of mucinous tumors of the ovary. Gynecol Oncol. 2006;103:171–5.

    Article  PubMed  Google Scholar 

  43. Krigman H, Bentley R, Robboy SJ. Pathology of epithelial ovarian tumors. Clin Obstet Gynecol. 1994;37:475–91.

    Article  CAS  PubMed  Google Scholar 

  44. Lalwani N, Shanbhogue AK, Vikram R, et al. Current update on borderline ovarian neoplasms. AJR Am J Roentgenol. 2010;194:330–6.

    Article  PubMed  Google Scholar 

  45. Leake JF, Currie JL, Rosenshein NB, et al. Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol. 1992;47:150–8.

    Article  CAS  PubMed  Google Scholar 

  46. Marret H, Sauget S, Giraudeau B, et al. Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses. J Ultrasound Med. 2004;23:1629–39.

    PubMed  Google Scholar 

  47. Milojkovic M, Hrgovic Z, Hrgovic I, et al. Significance of CA 125 serum level in discrimination between benign and malignant masses in the pelvis. Arch Gynecol Obstet. 2004;269:176–80.

    Article  PubMed  Google Scholar 

  48. Morice P. Borderline tumours of the ovary and fertility. Eur J Cancer. 2006;42:149–58.

    Article  CAS  PubMed  Google Scholar 

  49. Morice P, Camatte S, El Hassan J, et al. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril. 2001;75:92–6.

    Article  CAS  PubMed  Google Scholar 

  50. Nam EJ, Yun MJ, Oh YT, et al. Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI. Gynecol Oncol. 2010;116:389–94.

    Article  PubMed  Google Scholar 

  51. Orden MR, Jurvelin JS, Kirkinen PP. Kinetics of a US contrast agent in benign and malignant adnexal tumors. Radiology. 2003;226:405–10.

    Article  PubMed  Google Scholar 

  52. Osmers RGW, Osmers M, von Maydell B, et al. Preoperative evaluation of ovarian tumors in premenopause by transvaginosonography. Am J Obstet Gynecol. 1996;175:428–34.

    Article  CAS  PubMed  Google Scholar 

  53. Osmers RGW, Osmers M, von Maydell B, et al. Evaluation of ovarian tumors in postmenopausal women by transvaginal sonography. Eur J Obstet Gynecol Reprod Biol. 1998;77:81–8.

    Article  CAS  PubMed  Google Scholar 

  54. Paulsen T, Kærn J, Tropé C. Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery. Gynecol Oncol. 2011;122:83–8.

    Article  CAS  PubMed  Google Scholar 

  55. Prat J, De Nictolis M. Serous borderline tumors of the ovary. A long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol. 2002;26:1111–28.

    Article  PubMed  Google Scholar 

  56. Prayson RA, Hart WR, Petras RE. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. Am J Surg Pathol. 1994;18:591–603.

    CAS  PubMed  Google Scholar 

  57. Risum S, Hogdall C, Loft A, et al. The diagnostic value of PET/CT for primary ovarian cancer—a prospective study. Gynecol Oncol. 2007;105:145–9.

    Article  PubMed  Google Scholar 

  58. Ronnett BM, Kurman RJ, Zahn CM, et al. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol. 1995;26:509–24.

    Article  CAS  PubMed  Google Scholar 

  59. Russel P. Surface epithelial-stromal tumors of the ovary. In: Ed Kurman RJ, editor. Blaunstein’s pathology of the female genital tract. 4th ed. New York/Berlin/Heidelberg: Springer; 1994. p. 705–82.

    Chapter  Google Scholar 

  60. Rutgers JL, Scully RE. Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy of mullerian type. A clinicopathologic analysis. Cancer. 1988;61:546–54.

    Article  CAS  PubMed  Google Scholar 

  61. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol. 1996;20:1331–45.

    Article  CAS  PubMed  Google Scholar 

  62. Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol. 2000;31:539–57.

    Article  CAS  PubMed  Google Scholar 

  63. Seidman JD, Soslow RA, Vang R, et al. Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images. Hum Pathol. 2004;35:918–33.

    Article  PubMed  Google Scholar 

  64. Sherman ME, Mink PJ, Curtis R, et al. Survival among women with borderline ovarian tumors and ovarian carcinoma. A population-based analysis. Cancer. 2004;100:1045–52.

    Article  PubMed  Google Scholar 

  65. Shih I-M, Kurman RJ. Ovarian tumorigenesis-a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004;164:1511–8.

    Article  CAS  PubMed  Google Scholar 

  66. Shih I-M, Kurman RJ. Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges. Clin Cancer Res. 2005;11:7273–9.

    Article  CAS  PubMed  Google Scholar 

  67. Silva EG, Gershenson DM, Malpica A, et al. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Am J Surg Pathol. 2006;30:1367–71.

    Article  PubMed  Google Scholar 

  68. Singer G, Kurman RJ, Chang H-W, et al. Diverse tumorigenic pathways in ovarian serous carcinoma. Am J Pathol. 2002;160:1223–8.

    Article  CAS  PubMed  Google Scholar 

  69. Smith Sehdev AE, Sehdev PS, Kurman RJ. Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases. Am J Surg Pathol. 2003;27:725–36.

    Article  PubMed  Google Scholar 

  70. Sohaib SA, Sahdev A, Van Trappen P, Jacobs IJ, Reznek RH. Characterization of adnexal mass lesions on MR imaging. AJR Am J Roentgenol. 2003;180:1297–304.

    Article  PubMed  Google Scholar 

  71. Suh-Burgmann E. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study. Gynecol Oncol. 2006;103:841–7.

    Article  PubMed  Google Scholar 

  72. Taylor Jr HC. Malignant and semimalignant tumors of the ovary. Surg Gynecol Obstet. 1929;48:702–12.

    Google Scholar 

  73. Testa AC, Ferrandina G, Fruscella E, et al. The use of contrasted transvaginal sonography in the diagnosis of gynecologic diseases: a pre liminary study. J Ultrasound Med. 2005;24:1267–78.

    PubMed  Google Scholar 

  74. Testa AC, Timmerman D, Exacoustos C, et al. The role of CnTI-SonoVue in the diagnosis of ovarian masses with papillary projections: a preliminary study. Ultrasound Obstet Gynecol. 2007;29:512–6.

    Article  CAS  PubMed  Google Scholar 

  75. Testa AC, Timmerman D, Van Belle V, et al. Intravenous contrast ultrasound examination using contrast-tuned imaging (CnTI) and the contrast medium SonoVue for discrimination between benign and malignant adnexal masses with solid components. Ultrasound Obstet Gynecol. 2009;34:699–710.

    Article  CAS  PubMed  Google Scholar 

  76. Testa AC, Timmerman D, Van Holsbeke C, et al. Ovarian cancer arising in endometrioid cysts: ultrasound findings. Ultrasound Obstet Gynecol. 2011;38:99–106.

    Article  CAS  PubMed  Google Scholar 

  77. Timmerman D, Testa A, Bourne T, et al. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J Clin Oncol. 2005;23:8794–801.

    Article  PubMed  Google Scholar 

  78. Timmerman D, Van Calster B, Testa AC, et al. Ovarian cancer prediction in adnexal masses using ultrasound based logistic regression models: a temporal and external validation study by the IOTA group. Ultrasound Obstet Gynecol. 2010;36:226–34.

    Article  CAS  PubMed  Google Scholar 

  79. Tinelli R, Tinelli A, Tinelli FG, et al. Conservative surgery for borderline ovarian tumors: a review. Gynecol Oncol. 2006;100:185–91.

    Article  PubMed  Google Scholar 

  80. Tsili AC, Tsampoulas C, Charisiadi A, et al. Adnexal masses: accuracy of detection and differentiation with multidetector computed tomography. Gynecol Oncol. 2008;110:22–31.

    Article  CAS  PubMed  Google Scholar 

  81. Uzan C, Kane A, Rey A, et al. How to follow up advanced-stage borderline tumours? Mode of diagnosis of recurrence in a large series stage II–III serous borderline tumours of the ovary. Ann Oncol. 2011;22:631–5.

    Article  CAS  PubMed  Google Scholar 

  82. Valentin L, Ameye L, Jurkovic D, et al. Which extrauterine pelvic masses are difficult to correctly classify as benign or malignant on the basis of ultrasound findings and is there a way of making a correct diagnosis? Ultrasound Obstet Gynecol. 2006;27:438–44.

    Article  CAS  PubMed  Google Scholar 

  83. Valentin L, Ameye L, Testa A, et al. Ultrasound characteristics of different types of adnexal malignancies. Gynecol Oncol. 2006;102:41–8.

    Article  PubMed  Google Scholar 

  84. Valentin L, Jurkovic D, Van Calster B, et al. Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses. Ultrasound Obstet Gynecol. 2009;34:345–54.

    Article  CAS  PubMed  Google Scholar 

  85. Van Calster B, Timmerman D, Valentin L, et al. Triaging women with ovarian masses for surgery: observational diagnostic study to compare RCOG guidelines with an International Ovarian Tumour Analysis (IOTA) group protocol. BJOG. 2012;119:662–71.

    Article  PubMed  Google Scholar 

  86. Van Holsbeke C, Van Belle V, Leone FP, et al. Prospective external validation of the ‘ovarian crescent sign’ as a single ultrasound parameter to distinguish between benign and malignant adnexal pathology. Ultrasound Obstet Gynecol. 2010;36:81–7.

    Article  PubMed  Google Scholar 

  87. Vergote I, De Brabanter J, Fyles A, et al. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet. 2001;357:176–82.

    Article  CAS  PubMed  Google Scholar 

  88. Wong HF, Low JJ, Chua Y, et al. Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004. Int J Gynecol Cancer. 2007;17:342–9.

    Article  CAS  PubMed  Google Scholar 

  89. Yamamoto Y, Oguri H, Yamada R, et al. Preoperative evaluation of pelvic masses with combined (18)F-fluorodeoxyglucose positron emission tomography and computed tomography. Int J Gynaecol Obstet. 2008;102:124–7.

    Article  PubMed  Google Scholar 

  90. Yazbek J, Ameye L, Timmerman D, et al. Use of ultrasound pattern recognition by expert operators to identify borderline ovarian tumors: a study of diagnostic performance and interobserver agreement. Ultrasound Obstet Gynecol. 2010;35:84–8.

    Article  CAS  PubMed  Google Scholar 

  91. Yazbek J, Aslam N, Tailor A, et al. A comparative study of the risk of malignancy index and the ovarian crescent sign for the diagnosis of invasive ovarian cancer. Ultrasound Obstet Gynecol. 2006;28:320–4.

    Article  CAS  PubMed  Google Scholar 

  92. Yazbek J, Raju KS, Ben-Nagi J, et al. Accuracy of ultrasound subjective ‘pattern recognition’ for the diagnosis of borderline ovarian tumors. Ultrasound Obstet Gynecol. 2007;29:489–95.

    Article  CAS  PubMed  Google Scholar 

  93. Zanetta G, Lissoni A, Cha S, et al. Pre-operative morphological and colour Doppler features of borderline ovarian tumours. Br J Obstet Gynaecol. 1995;102:990–6.

    Article  CAS  PubMed  Google Scholar 

  94. Zanetta G, Rota S, Chiari S, et al. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol. 2001;19:2658–64.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Università degli Studi di Roma “Tor Vergata”, Ospedale Generale S. Giovanni Calibita ‘Fatebenefratelli’, Isola Tiberina 39, Rome, 0186, Italy

    Caterina Exacoustos

Authors
  1. Caterina Exacoustos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Caterina Exacoustos .

Editor information

Editors and Affiliations

  1. University of Cagliari, Cagliari, Italy

    Luca Saba

  2. Ngee Ann Polytechnic, Singapore, Singapore

    U. Rajendra Acharya

  3. University of Cagliari, Cagliari, Italy

    Stefano Guerriero

  4. Biomedical Technologies, Inc, Roseville, California, USA

    Jasjit S. Suri

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Exacoustos, C. (2013). Borderline Tumor (Serous/Mucinous/Endometrioid) (Clinical Setting and US). In: Saba, L., Acharya, U., Guerriero, S., Suri, J. (eds) Ovarian Neoplasm Imaging. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-8633-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8633-6_12

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4614-8632-9

  • Online ISBN: 978-1-4614-8633-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation